|
gptkbp:instanceOf
|
mental disorder
anxiety disorder
|
|
gptkbp:canBeChronic
|
true
|
|
gptkbp:canRemit
|
true
|
|
gptkbp:cause
|
gptkb:depression
substance abuse
avoidance behavior
functional impairment
|
|
gptkbp:complication
|
agoraphobia
|
|
gptkbp:diagnosedBy
|
gptkb:DSM-5_criteria
|
|
gptkbp:differentialDiagnosis
|
gptkb:arrhythmia
gptkb:generalized_anxiety_disorder
gptkb:social_anxiety_disorder
hyperthyroidism
|
|
gptkbp:firstDescribed
|
gptkb:Donald_Klein
|
|
gptkbp:gender
|
more common in women
|
|
gptkbp:hasEpisodicNature
|
true
|
|
gptkbp:hasGeneticComponent
|
true
|
|
gptkbp:hasNoClearPhysicalCause
|
true
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
panic disorder
|
|
gptkbp:ICD-10_code
|
F41.0
|
|
gptkbp:listedOn
|
gptkb:DSM-5
gptkb:ICD-10
|
|
gptkbp:onset
|
late adolescence or early adulthood
|
|
gptkbp:prevalence
|
about 2-3% of adults
|
|
gptkbp:riskFactor
|
family history
childhood abuse
major life stress
|
|
gptkbp:symptom
|
nausea
dizziness
shortness of breath
chest pain
sweating
palpitations
panic attack
trembling
fear of dying
fear of losing control
|
|
gptkbp:treatment
|
gptkb:psychotherapy
gptkb:drug
gptkb:SSRIs
gptkb:benzodiazepines
lifestyle modification
cognitive behavioral therapy
|
|
gptkbp:triggeredBy
|
caffeine
substance use
major stress
|
|
gptkbp:bfsParent
|
gptkb:Fear
gptkb:Zoloft
|
|
gptkbp:bfsLayer
|
5
|